Resynchronization reduces arginase activity in red blood cells of heart failure patients with dyssynchrony

Back

ESC2025 Premium Access

Resynchronization reduces arginase activity in red blood cells of heart failure patients with dyssynchrony

Session: Drugs, devices, and diagnostics in heart failure

Topic: Heart Failure with Reduced Ejection Fraction (HFrEF)

Speaker: Doctor K. Ljung (Stockholm, SE)

Event: ESC Congress 2025

Congress Presentation

Add to my library

About the speaker

Doctor Karin Ljung

Karolinska Institute, Stockholm (Sweden)

0 follower

7 more presentations in this session

Effects of beta-blockers on exercise capacity and hemodynamic response during CPET with echocardiography in heart failure with preserved ejection fraction

Speaker: Doctor S. Dhont (Genk, BE) Doctor P. Bertrand (Genk, BE)

Effects of sodium-glucose cotransporter-2 inhibitors on left ventricular-arterial coupling and myocardial extracellular volume in patients with type 2 diabetes mellitus and HFpEF

Speaker: Doctor A. Marathonitis (Athens, GR)

Finerenone-related risk of hypotension in patients with heart failure with mildly reduced or preserved ejection fraction

Speaker: Doctor A. Foa' (Bologna, IT)

Hemodynamic effects of lactate infusion in chronic heart failure patients

Speaker: Doctor N. Abild Jespersen (Aarhus N, DK)

Efficacy of glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes mellitus and chronic kidney disease

Speaker: Doctor D. Yoshiura (Tokyo, JP)

Access the full session

Drugs, devices, and diagnostics in heart failure

Speakers: Doctor K. Ljung, Doctor S. Dhont, Doctor P. Bertrand, Doctor A. Marathonitis, Doctor A. Foa'...

Access

About the event

ESC Congress 2025

29 August - 1 September 2025

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources

Explore sponsored resources